Medical specialists from Japan tagged as investigators in clinical trials studying Mantle Cell Lymphoma
Total 14 results
-
Dai MaruyamaSeen in:
- Tokyo, Koto, Cancer Institute Hospital of JFCR
- Tokyo, Koto, Japanese Foundation for Cancer Research
Trials:- NCT04662255 (Principal Investigator)
- NCT04965493 (Principal Investigator)
- NCT04666038 (Principal Investigator)
-
Daigo HashimotoSeen in:
- Hokkaido, Sapporo, Hokkaido University Hospital
Trials:- NCT04662255 (Principal Investigator)
- NCT04965493 (Principal Investigator)
- NCT04666038 (Principal Investigator)
- NCT05023980 (Principal Investigator)
-
Daisuke EnnishiSeen in:
- Okayama, Okayama University Hospital
Trials:- NCT04662255 (Principal Investigator)
- NCT04965493 (Principal Investigator)
- NCT04666038 (Principal Investigator)
- NCT05023980 (Principal Investigator)
-
Hiro TatetsuSeen in:
- Kumamoto, Kumamoto University Hospital
Trials:- NCT04662255 (Principal Investigator)
- NCT04965493 (Principal Investigator)
- NCT04666038 (Principal Investigator)
- NCT05254743 (Principal Investigator)
-
Hirokazu NagaiSeen in:
- Aichi, Nagoya, NHO Nagoya Medical Center
- Aichi, Nagoya, Nagoya Medical Center
Trials:- NCT04662255 (Principal Investigator)
- NCT04965493 (Principal Investigator)
- NCT04666038 (Principal Investigator)
- NCT05023980 (Principal Investigator)
-
Junya KurodaSeen in:
- Kyoto, GSK Investigational Site
- Kyoto, Kyoto-City, University Hospital - Kyoto Preferctural University of Medicine
- Kyoto, Kyoto-City, University Hospital Kyoto Prefectural University of Medicine
- Kyoto, Kyoto-shi, Kyoto Furitsu Medical University Hospital
- Kyoto, Kyoto-shi, University Hospital, Kyoto Prefectural University of Medicine
- Kyoto-shi, Kyoto Furitsu Medical University Hospital
Trials:- NCT04662255 (Principal Investigator)
- NCT04965493 (Principal Investigator)
- NCT03215030 (Principal Investigator)
- NCT04484623 (Principal Investigator)
-
Kensuke KojimaSeen in:
- Kochi, Nankoku, Kochi Medical School Hospital
Trials:- NCT04662255 (Principal Investigator)
- NCT04965493 (Principal Investigator)
- NCT04666038 (Principal Investigator)
- NCT05023980 (Principal Investigator)
-
Kensuke UsukiSeen in:
- Tokyo, Shinagawa-KU, NTT Medical Center Tokyo
- Tokyo, Shinagawa-Ku, NTT Medical Center Tokyo
Trials:- NCT04662255 (Principal Investigator)
- NCT04965493 (Principal Investigator)
- NCT04666038 (Principal Investigator)
-
Masahiro KizakiSeen in:
- Saitama, Kawagoe, Saitama Medical Center
Trials:- NCT04662255 (Principal Investigator)
- NCT04965493 (Principal Investigator)
- NCT05023980 (Principal Investigator)
-
Noriko FukuharaSeen in:
- Miyagi, Sendai-shi, Tohoku University Hospital
Trials:- NCT04662255 (Principal Investigator)
- NCT04965493 (Principal Investigator)
- NCT04666038 (Principal Investigator)
- NCT05023980 (Principal Investigator)
-
Ryusuke YamamotoSeen in:
- Hyogo, Kobe, Kobe City Medical Center General Hospital
Trials:- NCT04662255 (Principal Investigator)
- NCT04666038 (Principal Investigator)
-
Shigeru KusumotoSeen in:
- Aichi, Nagoya, Nagoya City University Hospital
Trials:- NCT04662255 (Principal Investigator)
- NCT04965493 (Principal Investigator)
- NCT04666038 (Principal Investigator)
-
Taiga KuroiSeen in:
- Hiroshima, Chugoku Central Hospital
- Hiroshima, GSK Investigational Site
Trials:- NCT04662255 (Principal Investigator)
- NCT04484623 (Principal Investigator)
Conditions: -
Takahiro KumodeSeen in:
- Osaka, Osaka Sayama-shi, Kindai University Hospital
Trials:- NCT04662255 (Principal Investigator)
- NCT04666038 (Principal Investigator)
Clinical Trials on Mantle Cell Lymphoma
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedRecurrent Mantle Cell Lymphoma | Stage III Mantle Cell Lymphoma | Stage IV Mantle Cell Lymphoma | Contiguous Stage II Mantle Cell Lymphoma | Noncontiguous Stage II Mantle Cell Lymphoma | Stage I Mantle Cell LymphomaUnited States
-
Northwestern UniversityNational Cancer Institute (NCI); Janssen Scientific Affairs, LLCActive, not recruitingStage III Mantle Cell Lymphoma | Stage IV Mantle Cell Lymphoma | Contiguous Stage II Mantle Cell Lymphoma | Noncontiguous Stage II Mantle Cell Lymphoma | Stage I Mantle Cell LymphomaUnited States
-
National Cancer Institute (NCI)CompletedStage III Mantle Cell Lymphoma | Stage IV Mantle Cell Lymphoma | Contiguous Stage II Mantle Cell Lymphoma | Noncontiguous Stage II Mantle Cell Lymphoma | Stage I Mantle Cell LymphomaUnited States
-
Roswell Park Cancer InstituteNational Comprehensive Cancer NetworkCompletedStage III Mantle Cell Lymphoma | Stage IV Mantle Cell Lymphoma | Stage I Mantle Cell Lymphoma | Stage II Contiguous Mantle Cell Lymphoma | Stage II Non-Contiguous Mantle Cell LymphomaUnited States
-
Burzynski Research InstituteWithdrawnRecurrent Mantle Cell Lymphoma | Stage III Mantle Cell Lymphoma | Stage IV Mantle Cell Lymphoma | Contiguous Stage II Mantle Cell Lymphoma | Noncontiguous Stage II Mantle Cell LymphomaUnited States
-
University of WashingtonNational Cancer Institute (NCI); National Comprehensive Cancer NetworkTerminatedRecurrent Mantle Cell Lymphoma | Refractory Mantle Cell Lymphoma | Ann Arbor Stage I Mantle Cell Lymphoma | Ann Arbor Stage II Mantle Cell Lymphoma | Ann Arbor Stage III Mantle Cell Lymphoma | Ann Arbor Stage IV Mantle Cell LymphomaUnited States
-
BeiGeneRecruitingMantle Cell Lymphoma | Relapsed Mantle Cell Lymphoma | Refractory Mantle Cell Lymphoma (MCL)United States, China, Israel, Belgium, Poland, Spain, Turkey, Brazil, Italy, Canada, United Kingdom, France, Germany, Argentina, Puerto Rico
-
BeiGeneCompletedRefractory Mantle Cell Lymphoma | Relapsed Mantle Cell LymphomaChina
-
Fondazione Italiana Linfomi - ETSRecruitingRefractory Mantle Cell Lymphoma | Relapsed Mantle Cell LymphomaItaly
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)TerminatedRecurrent Mantle Cell Lymphoma | Recurrent Non-Hodgkin Lymphoma | Refractory Non-Hodgkin Lymphoma | Refractory Mantle Cell Lymphoma | Central Nervous System Lymphoma | Gastric Mantle Cell Lymphoma | Splenic Mantle Cell LymphomaUnited States